Clinical Trials in New York

Showing 7761-7780 of 17,259 trials

Predicting Favorable Outcomes in Hospitalized Covid-19 Patients

NCT04570488

Testing use of predictive analytics to predict which COVID-19+ patients are at low risk for an adverse event (ICU transfer, intubation, mortality, hospice discharge, re-presentation to the ED, oxygen requirements exceeding nasal cannula at 6L/Min) in the next 96 hours

COVIDCorona Virus InfectionAdverse Event

NYU Langone Health1,415 participantsStarted May 2020

New York, New York, United States

COMPLETEDPhase 1/2< 1 mile

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

NCT00423514

RATIONALE: Giving chemotherapy, such as clofarabine, melphalan, and thiotepa, before a donor stem cell transplant helps stop the growth of cancer or abnormal cells. It also helps stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. Sometimes the transplanted cells from a donor can also make an immune response against the body's normal cells. Giving tacrolimus and mycophenolate mofetil before the transplant may stop this from happening. PURPOSE: This phase I/II trial is studying the side effects and best dose of clofarabine when given together with melphalan and thiotepa, followed by a donor stem cell transplant and to see how well it works in treating patients with high-risk and/or advanced hematologic cancer or other disease.

Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes

Memorial Sloan Kettering Cancer Center38 participantsStarted Nov 2006

New York, New York, United States

TERMINATEDNA< 1 mile

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

NCT03618095

REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects

Aortic Valve Stenosis

Boston Scientific Corporation382 participantsStarted Jan 2019

Huntsville, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +47 more locations

Predicting Favorable Outcomes in Hospitalized Covid-19 Patients

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

Find Trials by Condition in New York

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma

Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

OLAParib COmbinations

Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI

Assessing Portal Hypertension With Methacetin Breath Test

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics